Evidence map›Paper›PMID 37004850›Full record

ArticleBiological psychiatry2023

GluN2D Subunit in Parvalbumin Interneurons Regulates Prefrontal Cortex Feedforward Inhibitory Circuit and Molecular Networks Relevant to Schizophrenia.

Dinesh Y Gawande, Kishore Kumar S Narasimhan, Gajanan P Shelkar, Ratnamala Pavuluri, Holly A F Stessman, Shashank M Dravid

Open access · greenAbstract read
In one paragraph

Article in Biological psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Effects of NMDA receptor antagonists on working memory and gamma oscillations, and the mediating role of the GluN2D subunit.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Current neuropharmacology · 2025
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Dinesh Y GawandeDepartment of Pharmacology and Neuroscience, Creighton University School of Medicine, Omaha, Nebraska.
Kishore Kumar S NarasimhanDepartment of Pharmacology and Neuroscience, Creighton University School of Medicine, Omaha, Nebraska. Electronic address: KishoreKumarsNarasimhan1@creighton.edu.
Gajanan P ShelkarDepartment of Pharmacology and Neuroscience, Creighton University School of Medicine, Omaha, Nebraska.
Ratnamala PavuluriDepartment of Pharmacology and Neuroscience, Creighton University School of Medicine, Omaha, Nebraska.
Holly A F StessmanDepartment of Pharmacology and Neuroscience, Creighton University School of Medicine, Omaha, Nebraska.
Shashank M DravidDepartment of Pharmacology and Neuroscience, Creighton University School of Medicine, Omaha, Nebraska. Electronic address: ShashankDravid@creighton.edu.
Creighton University · US

Funding

Trans-synaptic signaling complex in amygdala pain mechanismsR01NS118731 · NINDS · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI DRAVID, SHASHANK MANOHAR, NEUGEBAUER, VOLKER · 2020 to 2024
$2.7M
Function of glutamate delta-1 receptorR01MH116003 · NIMH · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI DRAVID, SHASHANK MANOHAR · 2018 to 2022
$1.9M
NMDA receptor subtypes in basal gangliaR21NS104705 · NINDS · CREIGHTON UNIVERSITY · PI DRAVID, SHASHANK MANOHAR · 2018 to 2019
$412k
NIMH NIH HHS R01 MH116003NINDS NIH HHS R01 NS118731NINDS NIH HHS R21 NS104705
6 · The paper itself

Abstract

backgroundParvalbumin interneuron (PVI) activity synchronizes the medial prefrontal cortex circuit for normal cognitive function, and its impairment may contribute to schizophrenia (SZ). NMDA receptors in PVIs participate in these activities and form the basis for the NMDA receptor hypofunction hypothesis of SZ. However, the role of the GluN2D subunit, which is enriched in PVIs, in regulating molecular networks relevant to SZ is unknown.

methodsUsing electrophysiology and a mouse model with conditional deletion of GluN2D from PVIs (PV-GluN2D knockout [KO]), we examined the cell excitability and neurotransmission in the medial prefrontal cortex. Histochemical, RNA sequencing analysis and immunoblotting were conducted to understand molecular mechanisms. Behavioral analysis was conducted to test cognitive function.

resultsPVIs in the medial prefrontal cortex were found to express putative GluN1/2B/2D receptors. In a PV-GluN2D KO model, PVIs were hypoexcitable, whereas pyramidal neurons were hyperexcitable. Excitatory neurotransmission was higher in both cell types in PV-GluN2D KO, whereas inhibitory neurotransmission showed contrasting changes, which could be explained by reduced somatostatin interneuron projections and increased PVI projections. Genes associated with GABA (gamma-aminobutyric acid) synthesis, vesicular release, and uptake as well as those involved in formation of inhibitory synapses, specifically GluD1-Cbln4 and Nlgn2, and regulation of dopamine terminals were downregulated in PV-GluN2D KO. SZ susceptibility genes including Disc1, Nrg1, and ErbB4 and their downstream targets were also downregulated. Behaviorally, PV-GluN2D KO mice showed hyperactivity and anxiety behavior and deficits in short-term memory and cognitive flexibility.

conclusionsThese findings demonstrate that GluN2D in PVIs serves as a point of convergence of pathways involved in the regulation of GABAergic synapses relevant to SZ.

Indexed as

ParvalbuminsSchizophreniaAnimalsInterneuronsMiceMice, KnockoutNerve Tissue ProteinsPrefrontal CortexReceptor, ErbB-4Receptors, N-Methyl-D-AspartateDisc1 protein, mouseGrin2d protein, mouseNerve Tissue ProteinsParvalbuminsReceptor, ErbB-4Receptors, N-Methyl-D-AspartateGABAergicGluN2DmPFCNrg1-ErbB4 signalingParvalbuminSchizophrenia

Identifiers

PMID37004850
PMCPMC10524289
OpenAlexW4362473522

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.